Recall StatusTerminated
Date Initiated2011-03-30
Date Terminated2011-12-02
Product Quantity1,212 units
Reason for Recall
The recall was was initiated because patient results with the IGFBP-3 ELISA kit may be elevated by 70% compared to stated expected ranges in the Instructions for Use (IFU).
Firm Action
Beckman Coulter sent a Product Corrective Action (PCA) letter with attached customer response form on March 30, 2011 to all customers who have the affected product, IGFBP- 3 Enzyme-Linked immunosorbent Assay ( ELISA) kit .This kit provides materials for the quantitative measurement of IGFBP-3 in serum. The letter informed the customers of the reason for recall, the products affected and actions to be taken.
Consignees were asked to share this information with their laboratory staff and retain the notification as part of their laboratory Quality System documentation. If they forwarded any of the affected product listed above to another laboratory, they were asked to provide a copy of the letter to them.
Beckman further asked consignees to complete and return the enclosed Response Form within 10 days so they are assured consignees have received this important communication.
Questions were directed to the Beckman Coulter Customer Support Center.
- Website: http://www.beckmancoulter.com/customersupport/support
- Phone, call 1-800-854-3633 in the United States and Canada
- Outside the United States and Canada contact local Beckman Coulter representative.
Root Cause
Process control
Distribution Pattern
Worldwide -- USA, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Greece, Hong Kong, India, Italy, Korea, Republic of, Lebanon, Luxembourg, Morocco, Netherlands, New Zealand, Puerto Rico, Syrian Arab Republic, Taiwan, Thailand, Turkey & United Kingdom
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.